摘要
长期以来,美国眼科临床指南(PPP)的过敏性结膜炎相关论述是各国眼科学者诊治过敏性结膜炎的重要参考之一。但应当看到,该PPP内容包含各种类型结膜炎,尤以感染性结膜炎为主,过敏性结膜炎诊断与治疗的阐述缺乏细则。因此,中华医学会眼科学分会角膜病学组于2017年组织并撰写了《我国过敏性结膜炎诊断和治疗专家共识(2018年)》(简称《专家共识》)。该《专家共识》概括了过敏性结膜炎诊疗相关研究的前沿和现状,更有助于推动我国过敏性结膜炎的规范化诊疗。主要要点包括:吸收并肯定了欧美过敏性结膜炎诊疗指南的精髓,将过敏性结膜炎分为5个亚类,强调在临床上区分增殖性与非增殖性过敏性结膜炎;提出了一套基于专家临床经验的分类方法,有助于疾病的定量分级;强调了双效药物作为首选治疗的重要性,提出使用皮质类固醇类药物和免疫抑制剂治疗过敏性结膜炎的原则及方案。考虑到文章篇幅,本文结合美国眼科学会结膜炎诊疗指南(PPP),针对我国《专家共识》的重点进行择要解读,以期与国内眼科同道分享过敏性结膜炎的最新诊疗经验。
For a long time,the Preferred Practice Pattern（ PPP） of American Academy of Ophthalmology related to allergic conjunctivitis is widely recommended for the diagnosis and treatment of allergic conjunctivitis among physicians. However,the PPP content contains various types of conjunctivitis,mainly infectious conjunctivitis yet allergic conjunctivitis lack of detailed rules. China Cornea Society organized and wrote the expert consensus of allergic conjunctivitis in China in 2017. The expert consensus summarizes the frontier and present situation of the research on allergic conjunctivitis,and aims to promote the standardized diagnosis and treatment of allergic conjunctivitis in China.Firstly,we divide allergic conjunctivitis into 5 subtypes,emphasizing on the clinical differentiation of proliferative and non-proliferative allergic conjunctivitis. Secondly,a classification method based on expert clinical experience is proposed,which contributes to the quantitative grading of diseases. Thirdly,the importance of dual-effect drugs as the first choice of treatment is emphasized. Finally,we put forward the principle and scheme of using steroids and immunosuppressive drugs for allergic conjunctivitis. Taking into account the length of the article,compared with Preferred Practice Pattern of Conjunctivitis,this article aimed at key points of the Chinese expert consensus,with a view to share with ophthalmologists about the latest experience in diagnosis and treatment of allergic conjunctivitis.
作者
洪佳旭
徐建江
HONG Jia-xu;XU Jian-jiang(Department of Ophthalmology,Eye Ear Nose and Throat Hospital of Fudan University,Shanghai 200031,China.)
出处
《中国眼耳鼻喉科杂志》
2018年第4期227-229,共3页
Chinese Journal of Ophthalmology and Otorhinolaryngology
